Research Site is a clinical research site located in Golden, Colorado, United States.
Crixeo Health Trust Score: 73/100 (FAIR). This profile has not yet been claimed by the site owner.
Research Site has participated in 10 clinical trials with 2 currently active.
Therapeutic areas: Elevated High-sensitivity C-Reactive Protein (hsCRP), Bone Pain in Stage I - III Breast Cancer, Post-Menopausal Osteoporosis.
Sponsors: AstraZeneca, Amgen, DalCor Pharmaceuticals.
Trust Score: 73/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Research Site has a Crixeo Trust Score of 73/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Research Site has 10 clinical trials on record, with 2 currently active. Their work covers Elevated High-sensitivity C-Reactive Protein (hsCRP), Bone Pain in Stage I - III Breast Cancer, Post-Menopausal Osteoporosis.
Yes — Research Site holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.